A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis

Z. Balogh, Sotirios N. Papazoglou, Marion Macleod, W. Watson Buchanan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A single-blind, crossover trial was carried out in 24 patients with definite or classical rheumatoid arthritis to compare the effectiveness and tolerability of piroxicam (20 mg once daily) with that of indoniethacin (25 mg 3-times daily), ibuprofen (400 mg 3-times daily) and placebo. Each drug was given in random order for a period of 1 week. Pain, joint tenderness and morning stiffness decreased and grip strength increased with piroxicam compared to placebo; no statistically significant difference could be found between piroxicam and the two other active agents. A reduction in joint circumference could not be demonstrated with piroxicam or ibuprofen but most patients did not have reducible swelling in their finger joints. Piroxicam was just as effective as the other two drugs overall, but fewer side-effects were noted with piroxicam.

Original languageEnglish
Pages (from-to)148-153
Number of pages6
JournalCurrent Medical Research and Opinion
Volume6
Issue number2
DOIs
Publication statusPublished - 1979

Fingerprint

Piroxicam
Ibuprofen
Indomethacin
Cross-Over Studies
Rheumatoid Arthritis
Clinical Trials
Placebos
Finger Joint
Arthralgia
Hand Strength
Pharmaceutical Preparations
Joints

Keywords

  • Anti-Inflammatory Agents
  • Arthritis
  • Ibuprofen
  • Indomethacin
  • Piroxicani
  • Rheumatoid

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis. / Balogh, Z.; Papazoglou, Sotirios N.; Macleod, Marion; Buchanan, W. Watson.

In: Current Medical Research and Opinion, Vol. 6, No. 2, 1979, p. 148-153.

Research output: Contribution to journalArticle

Balogh, Z. ; Papazoglou, Sotirios N. ; Macleod, Marion ; Buchanan, W. Watson. / A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis. In: Current Medical Research and Opinion. 1979 ; Vol. 6, No. 2. pp. 148-153.
@article{a5002706ce8e4a4fac0edc3878f999ff,
title = "A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis",
abstract = "A single-blind, crossover trial was carried out in 24 patients with definite or classical rheumatoid arthritis to compare the effectiveness and tolerability of piroxicam (20 mg once daily) with that of indoniethacin (25 mg 3-times daily), ibuprofen (400 mg 3-times daily) and placebo. Each drug was given in random order for a period of 1 week. Pain, joint tenderness and morning stiffness decreased and grip strength increased with piroxicam compared to placebo; no statistically significant difference could be found between piroxicam and the two other active agents. A reduction in joint circumference could not be demonstrated with piroxicam or ibuprofen but most patients did not have reducible swelling in their finger joints. Piroxicam was just as effective as the other two drugs overall, but fewer side-effects were noted with piroxicam.",
keywords = "Anti-Inflammatory Agents, Arthritis, Ibuprofen, Indomethacin, Piroxicani, Rheumatoid",
author = "Z. Balogh and Papazoglou, {Sotirios N.} and Marion Macleod and Buchanan, {W. Watson}",
year = "1979",
doi = "10.1185/03007997909109412",
language = "English",
volume = "6",
pages = "148--153",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - A crossover clinical trial of piroxicam, indomethacin and ibuprofen in rheumatoid arthritis

AU - Balogh, Z.

AU - Papazoglou, Sotirios N.

AU - Macleod, Marion

AU - Buchanan, W. Watson

PY - 1979

Y1 - 1979

N2 - A single-blind, crossover trial was carried out in 24 patients with definite or classical rheumatoid arthritis to compare the effectiveness and tolerability of piroxicam (20 mg once daily) with that of indoniethacin (25 mg 3-times daily), ibuprofen (400 mg 3-times daily) and placebo. Each drug was given in random order for a period of 1 week. Pain, joint tenderness and morning stiffness decreased and grip strength increased with piroxicam compared to placebo; no statistically significant difference could be found between piroxicam and the two other active agents. A reduction in joint circumference could not be demonstrated with piroxicam or ibuprofen but most patients did not have reducible swelling in their finger joints. Piroxicam was just as effective as the other two drugs overall, but fewer side-effects were noted with piroxicam.

AB - A single-blind, crossover trial was carried out in 24 patients with definite or classical rheumatoid arthritis to compare the effectiveness and tolerability of piroxicam (20 mg once daily) with that of indoniethacin (25 mg 3-times daily), ibuprofen (400 mg 3-times daily) and placebo. Each drug was given in random order for a period of 1 week. Pain, joint tenderness and morning stiffness decreased and grip strength increased with piroxicam compared to placebo; no statistically significant difference could be found between piroxicam and the two other active agents. A reduction in joint circumference could not be demonstrated with piroxicam or ibuprofen but most patients did not have reducible swelling in their finger joints. Piroxicam was just as effective as the other two drugs overall, but fewer side-effects were noted with piroxicam.

KW - Anti-Inflammatory Agents

KW - Arthritis

KW - Ibuprofen

KW - Indomethacin

KW - Piroxicani

KW - Rheumatoid

UR - http://www.scopus.com/inward/record.url?scp=0018581581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018581581&partnerID=8YFLogxK

U2 - 10.1185/03007997909109412

DO - 10.1185/03007997909109412

M3 - Article

VL - 6

SP - 148

EP - 153

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 2

ER -